Global Cell Free DNA Isolation and Extraction Market

Focus on 25 country Analysis, Competitive Landscape, Applications (NIPT, Oncology, etc.), Product and Platform- Analysis and Forecast 2018-2026

Published Year: 2018
SKU: BH00590SA

4749

Online Access for One Person. Permission to Print

A quick peek into the report

Market Overview

Cell free DNA isolation and extraction market is anticipated to grow over $442.8 Million with 14,638.3 Thousand units by 2026.

Biomarker play an important role in development of translational medicine, which facilitates translation of basic research into medical advances. In line with this, most pharmaceutical and biotechnology companies are committing to associate their therapeutic drugs with diagnostic assays to monitor the drug response as number of biomarkers are directly associated with drugs. For instance, Thermo Fisher Scientific in collaboration with Novartis AG, Pfizer Inc. and GlaxoSmithKline Plc. is developing multi-market universal next-generation sequencing for multiple companion diagnostic programs, which will help pharma companies to match cancer patients with specific drug candidate

Early detection of cancer requires suitable diagnostic procedures to screen asymptomatic population which is on average risk of cancer, particularly for breast cancer, cervical cancers, colon cancers and melanoma. Increasing awareness of early signs and symptoms of cancer among physicians and other healthcare professionals as well as among general population. Governments in developed countries such as the U.S. raise funds for cancer research to aid in the diagnosis and treatment. Clinical trials are also funded by governments to support companies in developing effective diagnostic tests for cancer. The cell-free DNA isolation and extraction market drivers includes inclusion of cancer screening tests in national cancer screening programs, increasing discretionary funding for cancer research, associating drugs with diagnostic assays, constantly growing list of cancer biomarkers, exploring next-generation sequencing techniques for cancer diagnostics and others. Market restrains includes lack of standardization and appropriate controls of cell free DNA kits, insurance coverage and reimbursement issues and enormous R&D investment with no therapeutic result.

The global cell free DNA isolation and extraction market is anticipated to grow over $442.8 Million with 14,638.3 Thousand units by 2026, aided by the rising demand for non-invasive prenatal testing among high risk pregnant women and increased demand for liquid biopsy. North America is the leading contributor to the global cell free DNA isolation and extraction market, in terms of both, volume and revenue. The contribution of North America to the global cell free DNA isolation and extraction market was volume and valued to be approximately 59% and 61% in 2016, respectively. However, Asia Pacific is expected to grow, by volume, at an impressive 21.15% CAGR during the forecast period. The extraction kits hold the largest share of the total cfDNA extraction/isolation market and growing at a double digit CAGR. Furthermore, with magnetic bead-based kits, proteinase and heat treatment are unnecessary, enabling all the processes to be conducted at room temperature. As compared to traditional cfDNA extraction methods, there is also a significant reduction in processing and hands-on time.

Among the applications, non-invasive prenatal testing (NIPT) leads the cfDNA extraction/isolation market share. In 2016, the NIPT segment accounted for 72% of the total market. However, the market share of NIPT segment is expected to decrease substantially during the forecast period owing high market penetration rate of cfDNA technology in the cancer diagnostic and screening application. In 2016, next generation sequencing was the most used downstream quantification technique for cfDNA and accounted for 71% of the total sample processing share and is expected to remain the leading quantification technique in 2026.

This market intelligence report provides a multidimensional view of the global cell free DNA isolation and extraction market in terms of market size and growth potential. This research report aims at answering various aspects of the global cell free DNA isolation and extraction market with the help of the key factors driving the market, threats that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion.

Furthermore, the competitive landscape chapter in the report explicates the competitive nature of the global market and enables the reader to get acquainted with the recent market activities, such as product launches, regulatory clearance, and certifications, partnerships, collaborations, business expansions as well as mergers and acquisitions, among others. The research report provides a comprehensive analysis of the product sales, and manufacturers, and trend analysis by segments and demand analysis by geographical regions.

The report also profiles  companies including several key players, such as Agilent Technologies, Inc., Berry Genomics, BGI Diagnostics, BioCAT GmbH, F. Hoffmann-La Roche AG, GATC Biotech AG., Illumina, Inc., Laboratory Corporation of America, LifeCodexx AG, Merck KGaA, Natera Inc., NIPD Genetics, Norgen Biotek Corp., PreAnalytiX GmbH, Premaitha Health Plc, QIAGEN, Quest Diagnostics, SeraCare Life Sciences, Inc., STRATEC Biomedical AG, Thermo Fisher Scientific, AccuBioMed, Aline Biosciences, BioChain, Bioo Scientific Corporation, COVARIS, INC., Epigentek Group Inc., NeoGenStar LLC, Omega Bio-tek, Inc, Promega Corporation, System Biosciences, LLC., and STRECK, INC.,  among others.

Key Questions Answered in this Report

What are the major market drivers, challenges and opportunities in the Cell-free DNA testing market?

The answers to the following key questions can be derived from this report:

•    What are the major market drivers, challenges and opportunities in the Cell-free DNA testing market?
•    What was the market value of the leading segments and sub-segments of the global Cell-free DNA testing in 2016?
•    How will each segment of the global Cell-free DNA testing market grow during the forecast period and what will be the revenue generated by each of the segments by the end of 2026?
•    What are the influencing factors that may affect the market share of the key players in Cell-free DNA testing market?
•    How will the Cell-free DNA testing industry evolve during the forecast period 2018- 2026?
•    What are the key developmental strategies that are being implemented by the key players to sustain in this market?
•    What is the market share of each of the companies by NIPT test providers?
•    What is the growth-share matrix of each of the companies by NIPT test providers?
•    Who are the key players in the Cell-free DNA extraction/isolation kits market and what are their contributions?
•    What are the major benefits of the implementation of Cell-free DNA testing in the different field of applications including cancer diagnosis, prenatal testing, and several other chronic diseases?
•    What is the scope of Cell-free DNA testing in the emerging economies of the Asia Pacific and Latin America?
•    What is the scope for expansion by the key players of the Cell-free DNA testing market in the Asia Pacific and Latin America?

Report Description

Cell free DNA isolation and extraction market is anticipated to grow over $442.8 Million with 14,638.3 Thousand units by 2026.

Cell-free DNA are non-encapsulated DNA that enters the bloodstream during apoptosis or necrosis. This cell-free DNA is cleared by macrophages during normal body functioning, but overproduction of cells during cancer produces extra cfDNA in the blood. The CfDNA are found in blood, plasma, serum, or other body fluids and holds clinical significance in diagnosis, monitoring, and detection of various non-invasive diseases. The cfDNA is a screening method for tumors and other fetal DNA studies, they are challenging to extract as they are found in small quantities, and so reliable and consistent methods are required to isolate the less abundant cell-free DNA with higher sensitivity as they have a half-life of about two hours. The global cfDNA extraction and isolation industry is a multi-billion-dollar market which consists of multitudinous companies involved in the development of cfDNA extraction/isolation kits and automated instruments based on various sequencing platforms such as NGS and PCR to bolster the increasing demand for non-invasive screening tests and procedures.

cfDNA extraction and isolation products include extraction/isolation kit, automated instruments, and other consumables to improve the overall non-invasive screening process efficiency. Cell-free DNA testing is a new and efficient technology in which free-flowing DNA fragments from a liquid sample such as saliva, urine, and blood from patients are analyzed to screen a condition or disease. Cell-free DNA testing is essential solutions for the medical diagnostic companies that are facing increasing level of demand for high productivity and cost reduction. The recent advances in Cell-free DNA testing have paved the way for the development of multiple advanced technologies to aid in the battle against cancer and various other diseases including genetic and infectious diseases. The advent of screening procedures such as NIPT and liquid biopsy with improved efficiency of screening results are the most prominent factors facilitating the growth of Cell-free DNA testing in the medical diagnostic industry. Furthermore, these advanced testing procedures have also enabled the companies in the medical diagnostic industry to meet the regulatory compliance as well as manage their profit margins and remain competitive in the market.

The purpose of this study is to gain a holistic view of the Cell-free DNA testing market in terms of various influencing factors, such as recent trends and technological advancements. The scope of this report constitutes an in-depth study of the global Cell-free DNA testing market, including a thorough analysis of the products across different regions. The market has been segmented into ‘product’, ‘platform’, ‘application ‘and ‘regions’. The report presents the reader with an opportunity to unlock comprehensive insights concerning the market and helps in forming well informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering the market.

This research report aims at answering various aspects of the global Cell-free DNA testing market with the help of the key factors driving the market, restraints that can inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The report includes an in-depth examination of the key ecosystem players and key strategies and developments taking place in this market. Moreover, the report includes chapters on market dynamics (market drivers, opportunities and challenges) and industry analysis as well.

The research study considers the market share analysis for a comprehensive understanding of the global Cell-free DNA testing market and assesses the factors governing the same. Growth share matrix and detailed pricing analysis have been included in the report. The market by region has been further sub-segmented into various countries, and in each sub-segment, the key market trends, list of the key players, and the recent developments that have taken place have been discussed.

The key players who have been contributing significantly to the Cell-free DNA testing market include Agilent Technologies, Inc., Berry Genomics, BGI Diagnostics, BioCAT GmbH, F. Hoffmann-La Roche AG, GATC Biotech AG., Illumina, Inc., Laboratory Corporation of America, LifeCodexx AG, Merck KGaA, Natera Inc., NIPD Genetics, Norgen Biotek Corp., PreAnalytiX GmbH, Premaitha Health Plc, QIAGEN, Quest Diagnostics, SeraCare Life Sciences, Inc., STRATEC Biomedical AG, Thermo Fisher Scientific, AccuBioMed, Aline Biosciences, BioChain, Bioo Scientific Corporation, COVARIS, INC., Epigentek Group Inc., NeoGenStar LLC, Omega Bio-tek, Inc, Promega Corporation, System Biosciences, LLC., and STRECK, INC.,  among others.

Table of Contents

1 Market Overview

1.1    Introduction
1.2    Early Discovery and Applications of cfDNA
1.3    Properties of cfDNA
1.4    Biological Role of cfDNA
1.5    Extraction of Circulating cfDNA
1.6    Application of Circulating cfDNA
1.7    Addressable Market Size and Growth Potential
1.8    Recent Historical Trends 2013-2016 (Parent Market: Genomics)
1.9    Recent Historical Trends 2013-2016 (cfDNA)

2 Market Dynamics

2.1    Promoting and Inhibiting Factors of cfDNA Market Growth
2.2    Market Drivers
2.3    Market Restraints
2.4    Market Opportunities

3 Competitive Landscape

3.1    Key Develoments and Stratgies
3.2    Market Share Analysis by Company (2015 and 2016)
3.3    Value Chain Analysis

4 Pricing Analysis

4.1    cfDNA Extraction Kits Pricing Analysis

5 Global Cell Free DNA Extraction and Isolation Market, by Product

5.1    Analysis
5.2    Cell Free DNA Extraction and Isolation Kits
5.3    Cell Free DNA Automated Instruments
5.4    Consumables

6 Global Cell Free DNA Extraction and Isolation Market, by Platform

6.1    Introduction
6.2    Next Generation Sequencing
6.3    Polymerase Chain Reaction (PCR)
6.4    Others

7 Global Cell Free DNA Extraction and Isolation Market, by Applications

7.1    Overview
7.2    Non-Invasive Prenatal Testing (NIPT)
7.3    Oncology
7.4    Transplant Rejection and Other Disease Condition
7.5    Others

8 Global Cell Free DNA Extraction and Isolation Market, by Region

8.1    Overview
8.2    North America
        8.2.1    U.S.
        8.2.2    Canada
8.3    Europe
        8.3.1    Germany
        8.3.2    France
        8.3.3    U.K.
        8.3.4    Italy
        8.3.5    Spain
        8.3.6    Denmarrk
        8.3.7    Others
8.4    Asia Pacific
        8.4.1    China
        8.4.2    India
        8.4.3    Singapore
        8.4.4    Japan
        8.4.5    Others
8.5    Latin America
        8.5.1    Brazil
        8.5.2    Mexico
        8.5.3    Others
8.6    Rest of the World

9 Company Profiles

9.1    Overview
9.2    Agilent Technologies, Inc.
9.3    AccuBioMed
9.4    Aline Biosciences
9.5    Berry Genomics
9.6    BioChain
9.7    Bioo Scientific Corporation
9.8    BGI Diagnostics
9.9    BioCAT GmbH
9.1    Epigentek Group Inc.
9.11    F. Hoffmann-La Roche AG
9.12    GATC Biotech AG.
9.13    Illumina, Inc.
9.14    Laboratory Corporation of America
9.15    LifeCodexx AG
9.16    Merck KGaA
9.17    Natera Inc.
9.18    NIPD Genetics
9.19    Norgen Biotek Corp
9.2    PreAnalytiX GmbH
9.21    Premaitha Health Plc
9.22    GATC Biotech AG.
9.23    Illumina, Inc.
9.24    Laboratory Corporation of America
9.25    QIAGEN
9.26    Quest Diagnostics
9.27    SeraCare Life Sciences, Inc.
9.28    STRATEC Biomedical AG
9.29    Thermo Fisher Scientific
9.3    NeoGenStar LLC
9.31    Omega Bio-tek, Inc
9.32    Promega Corporation
9.33    System Biosciences, LLC.
9.34    STRECK, INC.

10 Report Scope & Methodology

10.1    Scope of the Report
10.2    Global Cell Free DNA Extraction and Isolation Market Segmentation
10.3    Research Methodology
        10.3.1    Primary Research
        10.3.2    Secondary Research
        10.3.3    Key Data Points from Primary Sources
        10.3.4    Key Data Points from Secondary Sources
        10.3.5    Data Triangulation
        10.3.6    Top-Down Approach (Segment wise Analysis)
        10.3.7    Bottom-Up Approach (Segmental Analysis)
10.4    Assumptions and Limitations
10.5    Data and Prediction Modelling

11 List of Tables

1    Global cfDNA Extraction/Isolation Market
2    Advanced Technologies Employed for Circulating cell-free DNA
3    Market Share Analysis
4    cfDNA Extraction Kits Pricing Analysis
5    Global cfDNA Extraction/Isolation Market by Product ($Million)
6    By Product : Extraction/Isolation Kits: Key Players
7    List of Some Commercially Available Isolation Kits 
8    Sales of Key Isolation Kits ($Million)
9    cfDNA Extraction/Isolation Kits Market by Method ($Million)
10    cfDNA Extraction/Isolation Kits Market by Method (Sample Processed, In Thousand Units)
11    By Product : Automated Instruments: Key Players 
12    By Product : Consumables: Key Players 
13    Product Analysis
14    Global cfDNA Extraction/Isolation Market by Platform ($Million)
15    Global cfDNA Extraction/Isolation Market by Platform (Sample Volume in Thousand)
16    Comparison between Next Generation Sequencing (NGS) and Polymerase Chain Reaction (dPCR)
17    Global cfDNA Extraction/Isolation Market by Application ($Million)
18    Global cfDNA Extraction/Isolation Market by Application (Sample Volume in Thousand)
19    Growth Share Matrix by cfDNA NIPT Test Providers
20    Global cfDNA Extraction/Isolation Market by Region ($Million)
21    Global cfDNA Extraction/Isolation Market by Region (Sample Volume in Thousand)
22    Key Players of North America
23    Key Players of Europe
24    Key Players of Asia Pacific
25    Key Players of Latin America and RoW
26    Latin America and RoW Market
27    List of Qiagen products for cfDNA
28    Thermo Fisher Scientific: Product Portfolio

List of Figures

1    Global cfDNA Extraction and Isolation Market, 2016 and 2026
2    Global cfDNA Extraction and Isolation Market Value & Forecast, 2016–2026 (US$ Million)
3    Global cfDNA Extraction/Isolation Market  Segmentation (Value)
4    Global cfDNA Extraction/Isolation Volume by Extraction Technology
5    Global cfDNA Extraction/Isolation Share by Extraction Technology, 2016
6    Global cfDNA Extraction/Isolation Share by Extraction Technology, 2026
7    Market Penetration of Automation Systems (Area Represent the Penetration Share), 2016
8    Global cfDNA Extraction/Isolation Market by Application (US$ Mn), 2016-2026
9    Global cfDNA Extraction/Isolation Market by Application, 2016
10    Global cfDNA Extraction/Isolation Market by Application, 2026
11    Global cfDNA Extraction/Isolation Market by Application (US$ Mn)
12    Global cfDNA Extraction/Isolation Market by End-User, 2016
13    Global cfDNA Extraction/Isolation Market by End-User, 2026
14    Global cfDNA Extraction/Isolation Market by Platform/technique (US$ Mn)
15    Global cfDNA Extraction/Isolation Market by Platform/technique, 2016
16    Global cfDNA Extraction/Isolation Market by Platform/technique (US$ Mn), 2026
17    Global cfDNA Extraction/Isolation Market by region, 2016
18    Global cfDNA Extraction/Isolation Market, by Region 2023
19    Global cfDNA Extraction/Isolation Market Growth Rate by Region
20    Global cfDNA Extraction/Isolation Market, 2016-2026 (US$ Mn)
21    Global cfDNA Extraction/Isolation Market, 2016-2026 (Sample processed Volume)
22    Global cfDNA Extraction/Isolation Market by Application ($Million)
23    Global cfDNA Extraction/Isolation Market by Application (Test Volume, Units)
24    Global cfDNA Extraction/Isolation Market ($Million)
25    Total cfDNA Isolation Volume by Major Countries ($Million), 2016 & 2026 
26    Global cfDNA Extraction/Isolation Market by Region 2016
27    Global cfDNA Extraction/Isolation Market by Region 2023
28    North America cfDNA Extraction/Isolation Market Growth Pattern, 2016-2026
29    Europe cfDNA Extraction/Isolation Market Growth Pattern, 2016-2027
30    Asia Pacific cfDNA Extraction/Isolation Market Growth Pattern, 2016-2026
31    Latin America cfDNA Extraction/Isolation Market Growth Pattern, 2016-2026
32    Global Research Genomics Market, 2016 (US$ Bn)
33    Global Clinical Genomics Market, 2016 (US$ Bn)
34    Recent Historical Trends 2013-2016 (cfDNA): Prenatal Testing 
35    Company/Laboratory Offering cfDNA Test (NIPT and Cancer)  
36    cfDNA Based Test Volume, 2011-2026
37    Market Share Analysis, 2015
38    Market Share Analysis, 2016
39    Value Chain 
40    Global cfDNA extraction/isolation market: By Product
41    Global cfDNA extraction/Isolation Market by Products ($Million)
42    Global cfDNA Extraction/Isolation Market Share by Product 2016 
43    Global cfDNA Extraction/Isolation Market Share by Product 2026
44    Global cfDNA Extraction/Isolation Kits Market ($Million)
45    Global cfDNA Automated Extraction System Market ($Million)
46    Global cfDNA Other Consumables Market ($Million)
47    Global Magnetic bead-based cfDNA Extraction Kits Market ($Million)
48    Global Magnetic bead-based cfDNA Extraction Kits Market (In Thousand Units) 
49    Global Column based cfDNA Extraction Kits Market (US$ Mn)
50    Global Column based cfDNA Extraction Kits Market (In Thousand Units) 
51    Global Other cfDNA Extraction Kits Market (US$ Mn)
52    Global Other cfDNA Extraction Kits Market (In Thousand Units) 
53    Global Automated Instruments cfDNA Extraction System Market ($Million)
54    Global Consumables cfDNA Extraction Market ($Million)
55    Global cfDNA Extraction/Isolation Market ($Million)
56    Global cfDNA Extraction/Isolation Market (Sample Volume, Thousand Units)
57    Global cfDNA Extraction Isolation Market Growth Rate by Revenue 
58    Global cfDNA Extraction Isolation Market Growth Rate by Volume 
59    Growth Share Matrix by Platform, 2016
60    cfDNA NGS Market, 2016-2026 ($Million)
61    cfDNA NGS Market, 2016-2026 (Test Volume, in Thousand Units) 
62    rPCR and Multiplexed PCR Based cfDNA Processing Volume (Thousand Units) 
63    rPCR and Multiplexed PCR Based cfDNA Processing Revenue
64    qPCR Based cfDNA Processing Revenue
65    qPCR Based cfDNA Processing Volume (Thousand Units) 
66    dPCR Based cfDNA Processing Volume (Thousand Units) 
67    dPCR Based cfDNA Processing Revenue
68    cfDNA Quantification Breakdown by Type of PCR, 2016
69    cfDNA Quantification Breakdown by Type of PCR, 2026
70    Global cfDNA Extraction/Isolation Market by Application ($Million)
71    Global cfDNA Extraction/Isolation Market by Application, 2016
72    Global cfDNA Extraction/Isolation Market by Application, 2026
73    Global Oncology cfDNA Extraction/Isolation Market ($Million)
74    Global Oncology cfDNA Extraction/Isolation Market (Test Volume, Thousand Units)
75    Cobas EGFR Mutation Test v2 Volume Growth Projection
76    Global NIPT cfDNA Extraction/Isolation Market ($Million)
77    Global NIPT cfDNA Extraction/Isolation Market (Test Volume, Thousand Units)
78    Global NIPT cfDNA Market Share Analysis (by Test Volume), 2016
79    Global NIPT cfDNA Market Share Analysis (by Test Volume), 2026
80    Growth Share Matrix by cfDNA NIPT Test Providers
81    Global NIPT Market Revenue by Region ($Million)
82    Global NIPT Test Volume by Region (Units)
83    Global Other cfDNA Extraction/Isolation Market ($Million)
84    Global Other cfDNA Extraction/Isolation Market (Test Volume, Thousand Units)
85    Global cfDNA Extraction/Isolation Market by Region, 2016
86    Global cfDNA Extraction/Isolation Market by Region, 2026
87    North America cfDNA Extraction/Isolation Market ($Million)
88    North America cfDNA Extraction/Isolation Market 
89    U.S. cfDNA Extraction Kits Market (US$ Mn)
90    U.S. cfDNA Extraction Kits Market (In Thousand Units) 
91    Canada cfDNA Extraction Kits Market (US$ Mn)
92    Canada cfDNA Extraction Kits Market (In Thousand Units) 
93    U.K. cfDNA Extraction Kits Market ($Million)
94    U.K. cfDNA Extraction Kits Market (In Thousand Units) 
95    Germany cfDNA Extraction Kits Market ($Million)
96    Germany cfDNA Extraction Kits Market (In Thousand Units) 
97    France cfDNA Extraction Kits Market ($Million)
98    France cfDNA Extraction Kits Market (In Thousand Units) 
99    Rest of Europe cfDNA Extraction Kits Market ($Million)
100    Rest of Europe cfDNA Extraction Kits Market (In Thousand Units) 
101    Asia Pacific cfDNA Extraction/Isolation Market ($Million)
102    China cfDNA Extraction Kits Market ($Million)
103    China cfDNA Extraction Kits Market (In Thousand Units) 
104    Japan cfDNA Extraction Kits Market ($Million)
105    Japan cfDNA Extraction Kits Market (In Thousand Units) 
106    India cfDNA Extraction Kits Market ($Million)
107    India cfDNA Extraction Kits Market (In Thousand Units) 
108    Agilent Technologies, Inc.: Product Portfolio
109    Agilent Technologies, Inc.: Overall Financials (2014-2016)
110    Agilent Technologies, Inc.: Revenue by Business Segment (2014-2016)
111    Agilent Technologies, Inc.: Revenue by Region (2014-2016)
112    Agilent Technologies, Inc.: SWOT Analysis
113    Berry Genomics: Product Portfolio
114    Berry Genomics: SWOT Analysis
115    BGI Diagnostics: Product Portfolio
116    BGI Diagnostics: SWOT Analysis
117    BioCAT GmbH: Product Portfolio
118    BioCat GmbH: SWOT Analysis
119    F. Hoffmann-La Roche AG: Product/Service Mapping
120    F. Hoffmann-La Roche AG: Net Revenue (2014-2016)
121    F. Hoffmann-La Roche AG: Revenue by Region (2014-2016)
122    F. Hoffmann-La Roche AG: Revenue by Divisions (2014-2016)
123    F. Hoffmann-La Roche AG: : Revenue By Diagnostics Sub-division (2014-2016)
124    F. Hoffmann-La Roche AG: SWOT Analysis
125    GATC Biotech AG: Product Portfolio
126    GATC Biotech AG: SWOT Analysis
127    Illumina, Inc.: Product Portfolio
128    Illumina, Inc.: Overall Financials (2014-2016)
129    Illumina, Inc.: Net revenue, Product revenue and Service revenue (2014-2016)
130    Illumina, Inc.: Revenue by Region, (2014-2016)
131    Illumina, Inc.: SWOT Analysis
132    Laboratory Corporation of America: Product/Service Portfolio
133    Laboratory Corporation of America: Overall Financials (2014-2016)
134    Laboratory Corporation of America: Revenue by Business Segment (2014-2016)
135    Laboratory Corporation of America: Geographic Distribution of Net Revenues (2016)
136    Laboratory Corporation of America: SWOT Analysis
137    LifeCodexx AG: Product Portfolio
138    LifeCodexx AG: SWOT Analysis
139    Merck KGaA: Product/Service Portfolio (Sigma-Aldrich, a Subsidiary of Merck)
140    Merck KGaA: Overall Financials (2014-2016)
141    Merck KGaA: Net Revenue by Business Segments, (2014-2016)
142    Merck KGaA: Revenue by Region (2014-2016)
143    Merck KGaA: SWOT Analysis
144    Natera Inc.: Product/Service Portfolio
145    Natera Inc.: Overall Financials (2014-2016)
146    Natera Inc.: Revenue by Region (2014-2016)
147    Natera Inc.: SWOT Analysis
148    NIPD Genetics: Product Portfolio
149    NIPD Genetics: SWOT Analysis
150    Norgen Biotek Corp.: Product Portfolio
151    Norgen Biotek Corp.: SWOT Analysis
152    PreAnalytiX GmbH: Product Portfolio
153    PreAnalytiX GmbH: SWOT Analysis
154    Premaitha Health Plc: Product Portfolio
155    Premaitha Health Plc: Overall Financials (2014-2016)
156    Premaitha Health Plc: Revenue by Region (2014-2016)
157    Premaitha Health Plc: SWOT Analysis
158    QIAGEN: Product and Service Portfolio
159    QIAGEN: Overall Financials (2014-2016)
160    QIAGEN: Net Revenue by Business Segment (2014-2016)
161    QIAGEN: Net Revenue by Region (2014-2016)
162    QIAGEN: SWOT Analysis
163    Quest Diagnostics: Product Portfolio
164    Quest Diagnostics: Overall Financials (2014-2016)
165    Quest Diagnostics: Revenue by Business Segment (2014-2016)
166    Quest Diagnostics: Revenue by DIS segment (2014-2016)
167    Quest Diagnostics: SWOT Analysis
168    SeraCare Life Sciences, Inc.: Product Portfolio
169    SeraCare Life Sciences, Inc.: SWOT Analysis
170    STRATEC Biomedical AG: Product Portfolio (Stratec Molecular GmbH, a subsidiary of Stratec Biomedical AG)
171    Stratec Biomedical AG: Overall Financials (2014-2016)
172    Stratec Biomedical AG: Revenue by Region (2014-2016)
173    Stratec Biomedical AG: Revenue by Business Segment (2014-2016)
174    Stratec Biomedical AG: Revenue by Business Segment 2014
175    STRATEC Biomedical AG: SWOT Analysis
176    Thermo Fisher Scientific: Overall Financials (2014-2016)
177    Thermo Fisher Scientific: Net Revenue by Business Segment (2014-2016)
178    Thermo Fisher Scientific: Net Revenue by Region (2014-2016)
179    Thermo Fisher Scientific: SWOT Analysis
180    AccuBioMed: Product Portfolio
181    Aline Biosciences: Product Portfolio
182    BioChain: Product Portfolio
183    Bioo Scientific Corporation: Product Portfolio
184    Covaris, Inc.: Product Portfolio
185    Epigentek Group Inc.: Product Portfolio
186    NeoGenStar LLC: Product Portfolio
187    Omega Bio-tek, Inc.: Product Portfolio
188    Promega Corporation: Product Portfolio
189    System Biosciences, LLC: Product Portfolio

Table
of Contents

Request a Sample

You may also like

Published Year: 2018

Global Liquid Biopsy Market: Focus on Products and Services, Therapeutic Applications, Clinical Applications, Circulating Biomarkers, Country Analysis (16 Countries), Industry Insights, and Competitive Landscape - Analysis and Forecast, 2018-2028

The global liquid biopsy market is anticipated to reach $2.94 billion by 2028, witnessing a...

 
Published Year: 2017

Global Non-Invasive Prenatal Testing (NIPT) Market -Analysis and Forecast (2017-2023)

North America was the largest market for NIPT in 2016 in terms of revenue and volume. The...

 
Published Year: 2016

Global Prenatal Testing Market – Analysis & Forecast 2016 – 2022

The global prenatal testing market is growing at a CAGR of 28.85% from 2016 to 2022 and is...

 
Published Year: 2016

Global Prenatal Testing and Newborn Screening Market : Forecast 2016-2022

Prenatal Testing and Newborn Screening is one of the most modernized trends in the healthcare...

 

Global Cell Free DNA Isolation and Extraction Market

Focus on 25 country Analysis, Competitive Landscape, Applications (NIPT, Oncology, etc.), Product and Platform- Analysis and Forecast 2018-2026